[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355736-105":59,"doc-detail-355736-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","plasma-fatty-acid-associated-with-risk-of-gastrointestinal-cancer-a-prospective-cohort-study-from-uk-biobank","Plasma fatty acid associated with risk of gastrointestinal cancer - a prospective cohort study from UK Biobank","","Gastrointestinal (GI) cancers remain a major cause of cancer-related mortality, and actionable biomarkers for prevention and risk stratification are still limited. This prospective cohort study assessed whether circulating plasma fatty acids relate to incident GI cancer in 91,239 cancer-free UK Biobank participants. Plasma fatty acids were measured by nuclear magnetic resonance spectroscopy, and incident GI cancers were tracked through national registries to 2020. Higher plasma polyunsaturated fatty acids were linked to lower overall GI cancer risk, with notable reductions for esophageal, colorectal, and liver cancers.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/plasma-fatty-acid-associated-with-risk-of-gastrointestinal-cancer-a-prospective-cohort-study-from-uk-biobank/355736/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/plasma-fatty-acid-associated-with-risk-of-gastrointestinal-cancer-a-prospective-cohort-study-from-uk-biobank/355736.png","ImageObject",300,407,{"name":92,"@type":93},"Cipher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the study objective regarding plasma fatty acids and GI cancer?","Question",{"text":113,"@type":114},"To prospectively assess the associations between plasma fatty acids and the risk of gastrointestinal cancer and to evaluate the clinical utility of these measurements for risk stratification and personalized prevention.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were plasma fatty acids measured and GI cancer outcomes identified?",{"text":118,"@type":114},"Plasma fatty acids were quantified using nuclear magnetic resonance (NMR) spectroscopy. Incident GI cancers were identified via national cancer registries through 2020 using ICD-10 codes.",{"name":120,"@type":111,"acceptedAnswer":121},"What did the study find about polyunsaturated fatty acids (PUFA) and GI cancer risk?",{"text":122,"@type":114},"Each one-standard-deviation increase in plasma PUFA levels was associated with a 21% reduced risk of overall GI cancer (HR 0.79, 95% CI 0.71–0.87). Significant risk reductions were also reported for esophageal, colorectal, and liver cancers.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},355736,1790147394,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},687208528416,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Original Article  \nPlasma fatty acid associated with risk of gastrointestinal cancer: a prospective cohort study from UK Biobank  \nTianyu Song1, Sien Hu1, Yongji Sun2,3,4, Jian Wu2,5, Yulian Wu2,3,4^, Xiawei Li2,3,4,6  \n1Department of General Surgery, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, China; 2Department of Surgery, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; 3Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Cancer Institute, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; 4Cancer Center, Zhejiang University, Hangzhou, China; 5School of Public Health, Zhejiang University School of Medicine, Hangzhou, China; 6Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA Contributions: (I) Conception and design: T Song, S Hu, Y Sun, X Li; (II) Administrative support: J Wu, Y Wu; (III) Provision of study materials or patients: X Li; (IV) Collection and assembly of data: S Hu; (V) Data analysis and interpretation: T Song, Y Sun; (VI) Manuscript writing: All authors;  \n(VII) Final approval of manuscript: All authors.  \nCorrespondence to: Xiawei Li, MD, MPH. Department of Surgery, Second Affiliated Hospital, Zhejiang University School of Medicine, No. 88, Jiefang Road, Shangcheng District, Hangzhou 310000, China; Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Cancer Institute, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Cancer Center, Zhejiang University, Hangzhou, China; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA. [Email: lixiawei@zju.edu.cn](Email: lixiawei@zju.edu.cn); Yulian Wu, MD, PhD. Department of Surgery, Second Affiliated Hospital, Zhejiang University School of Medicine, No.  \n88, Jiefang Road, Shangcheng District, Hangzhou 310000, China; Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Cancer Institute, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Cancer Center, Zhejiang University, Hangzhou, [China. Email: yulianwu@zju.edu.cn](China. Email: yulianwu@zju.edu.cn).  \nBackground: Gastrointestinal (GI) cancers represent a leading cause of cancer-related mortality worldwide, highlighting an urgent need for effective preventive approaches. While fatty acids (FAs) are implicated of carcinogenesis across multiple cancer types, their specific associations with GI cancer risk, and particularly their clinical utility as actionable biomarkers for risk stratification and personalized prevention within existing preventive frameworks, remain poorly understood. This study aimed to prospectively assess these associations and evaluate the clinical utility of plasma fatty acids for risk  \nstratification and personalized prevention.  \nMethods: This prospective cohort study included 91,239 cancer-free UK Biobank participants at baseline [2006–2010] . Plasma FAs were quantified using nuclear magnetic resonance (NMR) spectroscopy. Incident GI cancers [esophagus, stomach, colorectum, liver, bile duct, pancreas; International Classification of Diseases 10 (ICD-10) codes] were identified via national cancer registries through 2020. Multivariable Cox proportional hazards models estimated hazard ratios (HRs) for incident GI cancers, with comprehensive  \nadjustment for sociodemographic, lifestyle, and clinical covariates.  \nResults: During a median follow-up of 11.8 years, 1,519 incident GI cancer cases were documented.  \nCompared to non-cases, cases were older (mean age 60.8 vs. 55.5 years) and had a higher proportion of males (58.2% vs. 45.8%) . After comprehensive adjustment for sociodemographic factors [age, sex, family history, educational level, Townsend deprivation index (TDI)], lifestyle characteristics ","cbCaihvSwpGopnmN","https://ap.wps.com/l/cbCaihvSwpGopnmN","pdf",364924,11,"English","# Background\n# Methods\n# Results\n# Conclusions\n# Introduction","[{\"question\":\"What was the study objective regarding plasma fatty acids and GI cancer?\",\"answer\":\"To prospectively assess the associations between plasma fatty acids and the risk of gastrointestinal cancer and to evaluate the clinical utility of these measurements for risk stratification and personalized prevention.\"},{\"question\":\"How were plasma fatty acids measured and GI cancer outcomes identified?\",\"answer\":\"Plasma fatty acids were quantified using nuclear magnetic resonance (NMR) spectroscopy. Incident GI cancers were identified via national cancer registries through 2020 using ICD-10 codes.\"},{\"question\":\"What did the study find about polyunsaturated fatty acids (PUFA) and GI cancer risk?\",\"answer\":\"Each one-standard-deviation increase in plasma PUFA levels was associated with a 21% reduced risk of overall GI cancer (HR 0.79, 95% CI 0.71–0.87). Significant risk reductions were also reported for esophageal, colorectal, and liver cancers.\"}]","Plasma fatty acid associated with risk of gastrointestinal cancer - a prospective cohort study from UK Biobank | PDF",1790120689,28,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5d2de6cb13a43c2e026daff277812058.webp",983,1287,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8ae8681024c690a6fe4571c88028f8bc.webp",982,1286,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99e2140e3b1846aa524ddf69086d255c.webp",981,1284,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cd44874eafced05857f732851f92fcac.webp",980,1283]